Leaflet RESELIGO 3.6mg implant in pre-filled syringe
- Product code:
- W62378001
- Quantity:
- 1
- Indicated for:
- prostate cancer; breast cancer; endometriosis
- Route of administration:
- implantation
- Substance:
- goserelin (GnRH agonist)
- ATC
- L02AE03 — Antineoplastic and immunomodulating agents | Hormones and related agents | Gonadotropin releasing hormone analogues
Goserelin is a medication mainly used in the treatment of prostate cancer in men and breast cancer in women, as well as in some gynecological conditions such as endometriosis. It works by reducing the levels of certain hormones in the body, which helps slow down or stop the growth of cancer cells or abnormal tissue.
The medication is administered as a subcutaneous implant, usually once every few weeks or months, depending on your doctor's instructions. The treatment is closely monitored to assess effectiveness and adjust the dose if necessary.
Side effects may include hot flashes, sweating, decreased libido, mood changes, bone pain, or reactions at the implant site. In some cases, allergic reactions or changes in bone density may occur. Any unusual symptoms should be reported to your doctor.
Goserelin is an effective medication for controlling certain types of cancer and hormonal conditions, but it requires strict medical supervision. Follow the administration schedule and your doctor's instructions to achieve the best results and minimize risks.
The medication is administered as a subcutaneous implant, usually once every few weeks or months, depending on your doctor's instructions. The treatment is closely monitored to assess effectiveness and adjust the dose if necessary.
Side effects may include hot flashes, sweating, decreased libido, mood changes, bone pain, or reactions at the implant site. In some cases, allergic reactions or changes in bone density may occur. Any unusual symptoms should be reported to your doctor.
Goserelin is an effective medication for controlling certain types of cancer and hormonal conditions, but it requires strict medical supervision. Follow the administration schedule and your doctor's instructions to achieve the best results and minimize risks.
General data about RESELIGO 3.6mg
- Substance:
- goserelin
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W62378001
- Concentration:
- 3.6mg
- Pharmaceutical form:
- implant in pre-filled syringe
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 202.84 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for goserelin
Concentrations available for goserelin
- 10.8mg
- 3.6mg
Compensation lists for RESELIGO 3.6mg Alvogen
B - Sublist B with 50% discount from the reference price
- Price
- 202.84 RON
- Copayment
- 99.19 RON
- Patient
- 103.65 RON